
Erika Belard
Specialist physician and co-owner, CEO
Specialists in rheumatology assess and treat gout.
Gout (gouty arthritis, podagra) is a rheumatic disease in which uric acid forms crystals in the joints and tendons, triggering sudden, very painful attacks of joint inflammation – classically affecting the joint at the base of the big toe. The condition is caused by an excessively high level of uric acid (urate) in the blood, most often because the kidneys excrete too little. According to the Danish Society for Rheumatology, gout is the most common form of inflammatory arthritis and can be treated preventively so that attacks stop occurring. At Charlottenlund Privathospital, gout is assessed and treated by specialists in rheumatology at Jægersborg Allé 4 in Charlottenlund.
Gout belongs to the group of crystal arthropathies. When urate levels in the blood remain elevated for a prolonged period, needle-shaped urate crystals can form in the joints, tendons and tissues surrounding the joints. Crystals form most readily where the temperature is lower, which is why the feet and hands are most commonly affected. The crystals trigger a strong inflammatory reaction that presents as an acute attack. The term podagra refers specifically to an attack affecting the joint at the base of the big toe, which is the typical site of the first attack.
According to the Danish Society for Rheumatology’s national treatment guidelines, urate deposits can develop when the urate level in the blood exceeds approximately 0.40 mmol/L. Gout affects men more often than women and becomes more common with age. If left untreated, it can progress from isolated attacks to increasingly frequent attacks involving several joints and, over time, to chronic gout with visible urate deposits (tophi) and joint damage. With appropriate preventive treatment, this progression can be stopped and existing deposits can dissolve.
Acute attack
Sudden, severe joint inflammation – most commonly affecting the big toe. The joint becomes red, swollen, warm and extremely tender to touch. An untreated attack usually resolves within approximately 14 days and more quickly with treatment.
Between attacks
The joint is often completely normal, but urate crystals remain in the tissues. Without preventive treatment, attacks become more frequent and may affect additional joints.
Chronic gout
Persistent joint symptoms, hard urate deposits (tophi) under the skin and a risk of joint damage. This can be prevented, and tophi can dissolve when urate is maintained below the target level.
An attack often begins at night and develops over a few hours, reaching maximum pain within 24 hours. The joint becomes swollen, red, warm and so tender that even the light touch of a bedsheet can be unbearable. The first attack typically affects the joint at the base of the big toe, but the midfoot, ankle, knee, wrist and fingers can also be affected. An attack may be accompanied by a general feeling of being unwell and a mild fever. According to the treatment guidelines, an untreated attack usually resolves on its own within approximately 14 days – sooner with treatment for the acute attack.
Between attacks, the joint is often completely normal. Over time, attacks may occur more frequently, last longer and affect more joints. Some people develop hard lumps under the skin known as tophi, which are deposits of urate – typically around the ears, fingers, elbows or toes.
Uric acid is produced when purines from the body’s cells and from food are broken down. In most people, elevated blood urate levels are caused by reduced excretion through the kidneys. This may be hereditary or aggravated by high blood pressure, impaired kidney function and certain medicines, particularly diuretics. Being overweight, alcohol, sugary drinks and a purine-rich diet can also contribute. Gout frequently occurs alongside high blood pressure, obesity and type 2 diabetes, so the assessment also includes an evaluation of these risk factors.
The diagnosis is based on the patient’s medical history, examination of the affected joint and measurement of urate levels in the blood. According to the Danish Society for Rheumatology, the diagnosis is highly likely when a typical attack or tophi occur together with elevated urate levels – with the important exception that urate levels can be normal during an acute attack. The measurement is therefore repeated once the attack has settled.
Ultrasound can reveal characteristic signs of urate deposits in joints and tendons and is used to support the diagnosis and guide joint aspiration when necessary. X-rays may be relevant in longstanding disease. Other causes of a swollen, red joint – particularly joint infection, calcium pyrophosphate crystal arthritis and a flare-up of osteoarthritis – are always considered. In addition to urate, blood tests include inflammatory markers, kidney function and blood glucose.
Reduces inflammation during an acute attack.
Anti-inflammatory medication in tablet form – or an ultrasound-guided injection directly into the joint when a single joint is affected.
Lowers urate levels so that the crystals dissolve.
Daily urate-lowering medication. During the first few months, preventive medication against acute attacks is also given.
Until the target level is reached – and afterwards.
Blood tests, dose adjustments and advice on alcohol, sugary drinks, weight and fluid intake. Diuretic medication is reviewed in cooperation with the patient’s GP.
Treatment has two components. Treatment of an acute attack reduces inflammation using anti-inflammatory medication, colchicine or corticosteroids – either as tablets or as an injection directly into the joint. Preventive treatment lowers blood urate levels with medication so that new crystals do not form and existing crystals gradually dissolve. According to Danish and European guidelines, the treatment target is a urate level below 0.36 mmol/L, or below 0.30 mmol/L in patients with tophi. Levels are monitored with blood tests, and the dose is adjusted until the target is reached.
During the first few months after starting treatment, attacks may temporarily become more frequent, so preventive medication against acute attacks is given at the same time. Once the treatment target has been reached and maintained, attacks stop in the vast majority of patients and tophi gradually diminish. Advice on alcohol, sugary drinks, weight and fluid intake is also provided, and any use of diuretics is reviewed in cooperation with the patient’s GP. All treatment for gout can be provided on an outpatient basis at Charlottenlund Privathospital.
Calcium pyrophosphate crystal arthritis (previously known as pseudogout) is caused by deposits of calcium pyrophosphate crystals in the joint cartilage. It presents as acute attacks of joint inflammation, most commonly affecting the knee or wrist in people over the age of 60, and can be mistaken for gout or a joint infection. The diagnosis is made by identifying crystals in joint fluid and by X-ray or ultrasound, where calcification of the cartilage (chondrocalcinosis) may be visible. There is no medication that removes the crystals, so treatment focuses on managing acute attacks with anti-inflammatory medication, colchicine or joint injections. Calcium pyrophosphate crystal arthritis is assessed and treated on an outpatient basis by specialists in rheumatology.
A single typical attack can often be treated by your GP. A rheumatological assessment may be appropriate in cases of recurrent attacks, attacks affecting several or unusual joints, the presence of tophi, uncertainty about the diagnosis, failure of preventive treatment to reduce urate below the target level, or when kidney function or other medication complicates treatment. A swollen, red and very painful joint accompanied by fever should always be assessed by a doctor on the same day, as a joint infection must be ruled out.
Assessment and treatment are provided by specialists in rheumatology on an outpatient basis. The initial consultation typically lasts between 30 and 60 minutes. Blood tests and ultrasound can often be performed on the same day, and joint aspiration is carried out when required. Once the diagnosis has been confirmed, a plan is made for the treatment of acute attacks, preventive treatment and monitoring of urate levels, and the patient is followed by the same specialist.
Most patients attend through private health insurance. Insurance companies typically require a referral from the patient’s GP and prior authorisation before an appointment is booked. Self-paying patients do not require a referral, and prices are available in the price list. Appointments can be booked online around the clock or by calling 44 98 19 21 Monday to Friday from 08:00 to 14:00. Outside telephone hours, the digital telephone assistant Anna can book, cancel and reschedule appointments.
Podagra is the term for a gout attack in the joint at the base of the big toe. Gout is the condition; podagra is its most common first presentation.
Typically up to around 14 days if untreated. With treatment, it settles within a few days.
Yes. During an attack, urate levels may be normal or low. The test is therefore repeated once the attack has settled, and if there is any doubt, joint fluid is tested for crystals.
The condition cannot be cured, but preventive medication that keeps urate below 0.36 mmol/l stops attacks in most people, and deposits dissolve over time.
Usually, yes. If treatment is stopped, urate levels rise again and the attacks return. The decision is made together with the specialist, based on how the condition has progressed.
Alcohol—especially beer—and sugary drinks raise urate levels the most. Purine-rich foods such as organ meats and certain fish contribute to a lesser extent. Diet has a limited impact compared with medication, and advice is tailored to each person.
A type of crystal arthritis in which calcium pyrophosphate crystals form in the joint cartilage and cause attacks, most often in the knees or wrists of older people. It is treated during attacks, as medication cannot remove the crystals.
Yes—joint infection, calcium pyrophosphate crystal arthritis, osteoarthritis flare-ups and, rarely, rheumatoid arthritis. Joint fluid testing and ultrasound can help clarify the diagnosis.
Yes. For an attack affecting a single joint, a corticosteroid can be injected directly into the joint under ultrasound guidance if tablets are not suitable.
If you are using health insurance, your insurer will typically require a referral from your GP and prior authorisation. No referral is needed if you are paying for your treatment yourself.